Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4850957
Max Phase: Preclinical
Molecular Formula: C54H64N6O6
Molecular Weight: 893.14
Molecule Type: Unknown
Associated Items:
ID: ALA4850957
Max Phase: Preclinical
Molecular Formula: C54H64N6O6
Molecular Weight: 893.14
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C54H64N6O6/c61-45(55-33-11-13-39-37(23-33)53-17-19-57-29-31-15-21-65-41-27-47(63)59(39)51(53)49(41)35(31)25-43(53)57)9-7-5-3-1-2-4-6-8-10-46(62)56-34-12-14-40-38(24-34)54-18-20-58-30-32-16-22-66-42-28-48(64)60(40)52(54)50(42)36(32)26-44(54)58/h11-16,23-24,35-36,41-44,49-52H,1-10,17-22,25-30H2,(H,55,61)(H,56,62)/t35-,36-,41-,42-,43-,44-,49-,50-,51-,52-,53+,54+/m0/s1
Standard InChI Key: NCZVCWOBWGTWOF-WYDIPWKSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 893.14 | Molecular Weight (Monoisotopic): 892.4887 | AlogP: 6.98 | #Rotatable Bonds: 13 |
Polar Surface Area: 123.76 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.92 | CX Basic pKa: 9.37 | CX LogP: 3.93 | CX LogD: 0.59 |
Aromatic Rings: 2 | Heavy Atoms: 66 | QED Weighted: 0.16 | Np Likeness Score: 0.94 |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):